Loading...
•
Sep 30, 2021
West Pharma Q3 2021 Earnings Report
Announced third-quarter 2021 results and declared fourth-quarter 2021 dividend.
Key Takeaways
West Pharmaceutical Services, Inc. reported a strong third quarter in 2021, with net sales increasing by 28.9% to $706.5 million and adjusted-diluted EPS increasing by 79% to $2.06. The company is raising full-year 2021 net sales and adjusted-diluted EPS guidance.
Net sales of $706.5 million grew 28.9%; organic sales growth was 27.9%.
Reported-diluted EPS of $2.31 increased 112%.
Adjusted-diluted EPS of $2.06 increased 79%.
Company is raising full-year 2021 net sales guidance to a new range of $2.800 billion to $2.810 billion, compared to a prior range of $2.760 billion to $2.785 billion.
Revenue by Segment
Forward Guidance
Full-year 2021 net sales are expected to be in a range of $2.800 billion to $2.810 billion and adjusted-diluted EPS is expected to be in a range of $8.40 to $8.50.
Positive Outlook
- Full-year 2021 net sales are expected to be in a range of $2.800 billion to $2.810 billion.
- Organic sales growth is expected to be 28%.
- Full-year 2021 adjusted-diluted EPS is expected to be in a range of $8.40 to $8.50.
- Full-year adjusted-diluted EPS guidance range includes an estimated benefit of approximately $0.19 based on current foreign currency exchange rates.
- The revised guidance includes a $0.35 EPS positive impact of tax benefits from stock-based compensation from the first nine months of 2021.
Challenges Ahead
- Net sales guidance includes an estimated full-year 2021 benefit of $55 million based on current foreign exchange rates. This updated guidance is a reduction of $25 million, compared to a prior estimated full-year benefit of $80 million.
- Full-year adjusted-diluted EPS guidance range includes an estimated benefit of approximately $0.19 based on current foreign currency exchange rates. This updated guidance is a reduction of $0.08, compared to a prior estimated benefit of $0.27.
Revenue & Expenses
Visualization of income flow from segment revenue to net income
Historical Earnings Impact
Analyze how earnings announcements historically affect stock price performance
Avg. Return Before/After Earnings
Loading earnings performance data...
Loading earnings reaction data...